Trial Profile
To evaluate the tolerability and efficacy of Exenatide by race with basal insulin in patients with Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 Nov 2016 New trial record
- 02 Nov 2016 Results presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research